A biomimetic nanodisc system selectively activates type I interferons by nonclassical STING pathway for cancer immunotherapy
stem cell-like T cells. We thus manifest a strategy based on STING therapy that does not depend on the ER and Golgi apparatus pathways to activate the IFN-I pathway, for cancer immunotherapy.
Authors
- Shuo Li (ORCID: https://orcid.org/0009-0001-9636-9376)
- Xiunan Wang (ORCID: https://orcid.org/0000-0003-4070-4101)
- D. T. Sun
- Yue Xi (ORCID: https://orcid.org/0000-0002-8001-8969)
- Xi Liu (ORCID: https://orcid.org/0000-0002-6741-4094)
- Hao Liang (ORCID: https://orcid.org/0000-0001-7987-6002)
- Haolan Deng
- Xiaoyu An (ORCID: https://orcid.org/0009-0004-5975-0727)
- Qianwen Mu
Institutions
- Shenzhen University (CN)
- Xiamen University (CN)
- Xiamen University of Technology (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-03-31
- DOI
- https://doi.org/10.1038/s41467-026-71363-6
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00